Proton Pump Inhibitor Use and Risk of Gastric Cancer: Current Evidence from Epidemiological Studies and Critical Appraisal

Proton Pump Inhibitor Use and Risk of Gastric Cancer: Current Evidence from Epidemiological Studies and Critical Appraisal

Proton pump inhibitors (PPIs) are used for maintaining or improving gastric problems. Evidence from observational studies indicates that PPI therapy is associated with an increased risk of gastric cancer. However, the evidence for PPIs increasing the risk of gastric cancer is still being debated. Th...

Full description

Bibliographic Details
Main Authors: Tahmina Nasrin Poly, Ming-Chin Lin, Shabbir Syed-Abdul, Chih-Wei Huang, Hsuan-Chia Yang, Yu-Chuan (Jack) Li
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Cancers
Subjects:
proton pump inhibitors
gastric cancer
stomach neoplasms
epidemiology
meta-analysis
Online Access:https://www.mdpi.com/2072-6694/14/13/3052

Internet

https://www.mdpi.com/2072-6694/14/13/3052

Similar Items